“…In the literature, segmental neurofibromatosis associated with skeletal abnormatilies, soft tissue hypertrophy, visceral neurofibromas, unilateral renal agenesis, renal angiomyolipoma and malignancies such as Hodgkin's lymphoma, colon carcinoma, gastric carcinoma, lung carcinoma, and peripheral nerve sheath tumour have been reported. 3,7,8,[12][13][14][15] The prevalence of segmental neurofibromatosis has been estimated to range between 0,0014% to 0,002%. We think that most of the cases are underdiagnosed because of the absence of symptoms.…”